Sanacorp Pharmaholding AG

EANS-Adhoc: Sanacorp Pharmaholding AG
Sanacorp disposes of Anzag investment

@@start.t1@@--------------------------------------------------------------------------------   ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro   adhoc with the aim of a Europe-wide distribution. The issuer is solely   responsible for the content of this announcement. --------------------------------------------------------------------------------@@end@@


The pharmaceutical wholesale company Sanacorp Pharmahandel GmbH ("Sanacorp GmbH"), which is indirectly owned by Sanacorp Pharmaholding Aktiengesellschaft via its 50 percent interest in the Italian holding company Sanastera S.p.A., Bologna, signed an agreement on October 18th., 2010 stipulating the sale of approximately 24.99% in the capital stock of Andreae-Noris Zahn AG, Frankfurt (WKN 504700/ISIN DE0005047005). Acquirer is an investment company of the Alliance Boots Group. The implementation of the share purchase agreement is subject to the responsible cartel authorities´ approval.

The purchase price agreed per share is EUR 26.00. Sanacorp GmbH will thus receive cash flows of more than EUR 69 million expected to be used for the settlement of liabilities.

Sanacorp Pharmaholding AG

The Management Board

@@start.t2@@end of announcement                                                 euro adhoc

ots Originaltext: Sanacorp Pharmaholding AG
Im Internet recherchierbar:

Further inquiry note:
Dr. Thomas Strieder
Phone: +49(89) 8581 494

Branche: Wholesale
ISIN:      DE0007163131
WKN:        716313
Index:    CDAX, Classic All Share
Börsen:  Berlin / free trade
              Hamburg / free trade
              Stuttgart / free trade
              Düsseldorf / free trade
              München / regulated dealing
              Frankfurt / regulated dealing/general standard

Weitere Meldungen: Sanacorp Pharmaholding AG

Das könnte Sie auch interessieren: